Order Article Reprints

Santoni G, Amantini C, Maggi F, Marinelli O, Santoni M, Morelli MB. The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib Treatment. Biomolecules. 2022; 12(1):107. https://doi.org/10.3390/biom12010107

Santoni, Giorgio, Consuelo Amantini, Federica Maggi, Oliviero Marinelli, Matteo Santoni, and Maria Beatrice Morelli. 2022. "The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib Treatment" Biomolecules 12, no. 1: 107. https://doi.org/10.3390/biom12010107

Santoni, G., Amantini, C., Maggi, F., Marinelli, O., Santoni, M., & Morelli, M. B. (2022). The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib Treatment. Biomolecules, 12(1), 107. https://doi.org/10.3390/biom12010107